Μετάβαση στο περιεχόμενο
Ενδοθηλιακά κύτταρα της ανθρώπινης σαφενώδους φλέβας (HSVEC)
Ιστός
Saphenous vein
Ασθένεια
Normal saphenous vein endothelium (primary cells; non-tumorigenic)
Θέση μετάστασης
Not applicable (normal, non-tumorigenic primary cell)
Συνώνυμα
HSaVEC, HSVEC, Human saphenous vein endothelial cells, provitro 1210121

Έγγραφα

Ενδοθηλιακά κύτταρα της ανθρώπινης σαφενώδους φλέβας (HSVEC)

Primary cell · Αριθμός προϊόντος 300699

Venous endothelium for bypass graft research

€1,220.00χωρίς ΦΠΑ και έξοδα αποστολής

Προσαρμογή / Προτάσεις

Κατασκευάζεται κατόπιν παραγγελίας
1

01Γενικές πληροφορίες

Περιγραφή

Primary Human Saphenous Vein Endothelial Cells (HSaVEC) are isolated from the saphenous vein and offer a venous endothelial model alongside HUVEC. They are used in research on atherosclerosis, leukocyte adhesion and the endothelial failure of coronary bypass vein grafts.

HSaVEC show the typical cobblestone morphology and express CD31 and VE-cadherin. As cells from adult vessels, they differ from fetal HUVEC: they are more sensitive to oxidized LDL, respond less strongly to cytokines and can present antigen to T cells, making them a closer model of adult venous endothelium.

Ιστός
Saphenous vein
Ασθένεια
Normal saphenous vein endothelium (primary cells; non-tumorigenic)
Θέση μετάστασης
Not applicable (normal, non-tumorigenic primary cell)
Εφαρμογές
Adult endothelial model: ox-LDL, leukocyte adhesion, antigen presentation and tumor cell adhesion; Endothelial dysfunction in coronary bypass patients, screening of interventions; Mechanobiology: shear stress and arterial-level stretch in vein graft arterialization; Oxidative stress and mitophagy in vein graft failure; Insulin and IGF-1 receptor signaling in type 2 diabetes; Biomaterials: bioactive wound dressings for chronic wounds
Συνώνυμα
  • HSaVEC
  • HSVEC
  • Human saphenous vein endothelial cells
  • provitro 1210121

02Δωρητής

Ηλικία δωρητή
Lot-specific (see CoA)
Εθνικότητα
Lot-specific (see CoA)

03Ταξινόμηση

Οργανισμός
Άνθρωπος
Σεξ
Σχετικά με το συγκεκριμένο παρτίδα
Ιδιότητες ανάπτυξης
Πιστός
Κατάσταση όσον αφορά τους ΓΤΟ
Χωρίς ΓΤΟ
Λεπτομέρειες σχετικά με την κατάσταση των ΓΤΟ
No genetic modification; primary human endothelial cells isolated from saphenous vein tissue. Not transformed or immortalized.
Επίπεδο βιοασφάλειας
1

04Χαρακτηριστικά

Μορφολογία
Cobblestone (endothelial)
Τύπος κυττάρου
Primary endothelial cells
Ογκογόνος
No
Χρόνος διπλασιασμού
approx. 24 hours (under optimal EGM-2/EBM-2 conditions, Marelli-Berg et al. 2004)

05Χειρισμός και καλλιέργεια

Θρεπτικό μέσο
Endothelial Cell Growth Medium
Ατμόσφαιρα επώασης

37°C, 5% CO2, saturated humidity.

Συμπληρώματα
EGM-2-MV BulletKit supplements: hEGF, VEGF, hFGF-B, IGF-1, hydrocortisone, ascorbic acid, heparin, and 5% FBS (pre-formulated in EGM-2; no additional serum needed). Gelatin-coat culture vessels before seeding.
Αντιδραστήριο αποσύνδεσης
Subculture reagents as recommended on the certificate of analysis
Επίστρωση φιαλών
0.1–0.2% gelatin coating required (incubate gelatin solution 30 min at 37°C, aspirate excess before seeding)
Αναπαραγωγή σε υποκαλλιέργεια

Subculture the cells at about 75 % confluence. Denser cultures undergo irreversible contact inhibition and stop proliferating. Use the subculture reagents recommended on the certificate of analysis.

Αναλογία διαχωρισμού
1 to 3
Πυκνότητα σποράς
More than 6,000 cells/cm²
Ανανέωση υγρών
24 hours after seeding, then every 48 to 72 hours
Ανάκαμψη μετά την απόψυξη

Post-thaw viability ≥ 70 % viable cells. More than 80 % confluence within the expected recovery period.

Απόψυξη και καλλιέργεια
  1. Thaw the cryovial quickly in a 37 °C water bath, swirling gently. Just before the last ice has melted, move the vial to a laminar flow hood and decontaminate its outer surface.

  2. Transfer the cell suspension into a 15 ml centrifuge tube, add 10 ml of Endothelial Cell Growth Medium and centrifuge at 250 × g for 5 minutes.

  3. Remove the supernatant and resuspend the cell pellet in 10 ml of Endothelial Cell Growth Medium. Check cell number and viability.

  4. Divide the suspension between two 25 cm² culture flasks (5 ml each). Using two flasks reduces the risk of losing all cells if a passage fails.

  5. Incubate at 37 °C, 5 % CO₂ and saturated humidity, with the screw caps opened by half a turn for gas exchange.

  6. Change the medium after 24 hours to remove unattached cells, then every 48 to 72 hours, using pre-warmed medium only.

  7. Subculture the cells at about 75 % confluence. Denser cultures undergo irreversible contact inhibition and stop proliferating. Use the subculture reagents recommended on the certificate of analysis.

  8. Recommended seeding density: more than 6,000 cells/cm².

06Έλεγχος ποιότητας και κρυοσυντήρηση

Στειρότητα

Mycoplasma contamination is excluded by PCR.

To ensure there is no bacterial, fungal or yeast contamination, cultures are subjected to visual inspection.

Μέσο κατάψυξης
As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
Συνθήκες αποθήκευσης

For long-term preservation, store vials in liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable for up to one week only.

Όροι αποστολής

Cryopreserved primary cells are shipped on dry ice. On receipt, check the cryovial for damage and transfer it without delay to appropriate storage.

07Έκφραση και ευαισθησία

Επιφανειακά αντιγόνα
CD31 (PECAM-1); VE-cadherin (CD144); von Willebrand factor (vWF); eNOS; HLA-DR (inducible); ICAM-1 (inducible); VCAM-1 (inducible); E-selectin (inducible); UEA-I lectin binding
Υποδοχείς που εκφράζονται
VEGFR2 (KDR); VEGFR1; TIE-2; EGFR (low)

08Αναγνωριστικά

Παραπομπή
Human saphenous vein endothelial cells (HSVEC) (Cytion catalog number 300699)
Αριθμός φορολογικού μητρώου NCBI
9606
Κελλοσαύρος
Not assigned